Applied DNA Sciences, Inc.

$5.62+31.62%(+$1.35)
TickerSpark Score
50/100
Mixed
92
Valuation
35
Profitability
10
Growth
64
Health
50
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APDN research report →

52-Week Range1% of range
Low $2.13
Current $5.62
High $319.95

Companywww.adnas.com

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims.

CEO
James A. Hayward Sc.D.
IPO
2003
Employees
46
HQ
Stony Brook, NY, US

Price Chart

-97.50% · this period
$185.25$93.78$2.32Oct 31May 06Nov 03

Valuation

Market Cap
$7.26M
P/E
-0.12
P/S
0.25
P/B
0.32
EV/EBITDA
0.02
Div Yield
0.00%

Profitability

Gross Margin
43.49%
Op Margin
-1209.55%
Net Margin
-1646.94%
ROE
-337.10%
ROIC
-204.13%

Growth & Income

Revenue
$2.14M · -37.72%
Net Income
$-69,487,620 · -893.74%
EPS
$-134.23 · -7275.27%
Op Income
$-16,046,595
FCF YoY
11.07%

Performance & Tape

52W High
$319.95
52W Low
$2.13
50D MA
$3.55
200D MA
$35.61
Beta
0.13
Avg Volume
469.22K

Get TickerSpark's AI analysis on APDN

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Mar 23, 23Jantzen Bethother98,039
Mar 23, 23Jantzen Bethother91,667
Mar 23, 23Jantzen Bethother1,961
Mar 23, 23Shorrock Clayother98,039
Mar 23, 23Shorrock Clayother91,667
Mar 23, 23Shorrock Clayother1,961
Mar 23, 23Murrah Judithother99,306
Mar 23, 23Murrah Judithother98,039
Mar 23, 23Murrah Judithother10,294
Jan 25, 23SHAMASH YACOV Aother75,099

Our APDN Coverage

We haven't published any research on APDN yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate APDN Report →

Similar Companies